Virginia King received treatment for metastatic breast cancer at a hospital in Santa Fe, N.M., where she was billed $22,700 for a drug that cost $2,700. The hospital was part of a federal program allowing it to profit from the price difference. Apexus, a company managing the program, has been accused of maximizing profits and cashing in on the program’s growth, leading to increased health care costs.
Full Article
Loading PerspectiveSplit analysis...






